Descriptions

Cyclin-T1 (CycT1) combines with cyclin-dependent kinase (Cdk9) and this complex is called positive transcription elongation factor B (P-TEFb). An intramolecular interaction between the N- and C-terminal regions of cyclin T1 sterically masks the TAR-binding surface, thereby blocking the P-TEFb?TAR interaction. Binding of Tat-SF1 to the CycT1 C-terminal region disrupts the intramolecular interaction in CycT1, stabilizes the P-TEFb-Tat-TAR complex, and stimulates HIV-1 transcription. The efficient interaction between P-TEFb and TAR RNA requires suppression of the autoinhibitory activity of the CycT1 C-terminal region.

Autoinhibitory domains (AIDs)

Target domain

1-334 (N-terminal cyclin box)

Relief mechanism

PTM, Partner binding

Assay

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6T8E9

Entry ID Method Resolution Chain Position Source
AF-Q6T8E9-F1 Predicted AlphaFoldDB

85 variants for Q6T8E9

Variant ID(s) Position Change Description Diseaes Association Provenance
rs467202272 49 G>A No EVA
rs467186736 129 Q>E No EVA
rs876600889 134 V>A No EVA
rs452762025 138 S>T No EVA
rs471391746 143 T>P No EVA
rs447548099 195 V>E No EVA
rs464381073 206 K>N No EVA
rs433059716 208 S>P No EVA
rs451991688 258 W>S No EVA
rs446304277 263 A>P No EVA
rs463055308 264 D>H No EVA
rs467340579 269 A>G No EVA
rs450429305 269 A>T No EVA
rs446468023 275 D>N No EVA
rs459155931 315 P>T No EVA
rs209763046 322 S>N No EVA
rs432121038 394 R>L No EVA
rs452441602 401 L>W No EVA
rs475732696 411 M>R No EVA
rs437875679 419 Y>C No EVA
rs454966174 425 N>K No EVA
rs474998672 435 S>W No EVA
rs719701738 450 R>W No EVA
rs439724818 451 P>L No EVA
rs462969381 452 F>V No EVA
rs483252550 456 T>A No EVA
rs481037165 461 L>V No EVA
rs446559197 464 R>T No EVA
rs466593310 473 A>S No EVA
rs432033935 474 A>T No EVA
rs445890497 476 I>V No EVA
rs451228191 482 K>N No EVA
rs469167622 485 I>S No EVA
rs454703328 489 T>P No EVA
rs468599458 490 A>T No EVA
rs433942714 492 D>E No EVA
rs454219332 493 K>E No EVA
rs470940487 493 K>N No EVA
rs439663525 495 N>D No EVA
rs476570964 495 N>K No EVA
rs456615845 495 N>S No EVA
rs462397033 497 V>E No EVA
rs481074868 499 D>Y No EVA
rs440027263 502 T>K No EVA
rs477145196 513 T>I No EVA
rs469179674 514 H>R No EVA
rs448389467 519 H>Q No EVA
rs468409519 526 S>P No EVA
rs433851468 528 K>R No EVA
rs454069670 529 H>P No EVA
rs133730852 530 S>A No EVA
rs433261066 531 H>D No EVA
rs442158132 532 S>L No EVA
rs476632150 532 S>P No EVA
rs455900380 534 L>R No EVA
rs800620900 535 P>L No EVA
rs441500252 536 A>S No EVA
rs460174689 556 A>P No EVA
rs476955271 559 P>T No EVA
rs439329520 561 S>T No EVA
rs462617189 564 S>R No EVA
rs448216450 567 S>C No EVA
rs468372149 572 S>A No EVA
rs478992358 574 K>T No EVA
rs447509274 584 V>E No EVA
rs447509274 584 V>G No EVA
rs717437959 589 S>* No EVA
rs135032279 589 S>P No EVA
rs136608799 592 T>P No EVA
rs433120772 598 S>P No EVA
rs450112992 598 S>Y No EVA
rs470146281 605 F>L No EVA
rs455912876 609 P>T No EVA
rs798893223 613 Q>E No EVA
rs435088111 613 Q>H No EVA
rs451976075 614 L>V No EVA
rs435185599 615 P>T No EVA
rs470603632 620 D>E No EVA
rs439189927 631 C>Y No EVA
rs448809241 668 L>P No EVA
rs462529552 674 V>I No EVA
rs378858628 677 T>I No EVA
rs476332235 685 V>L No EVA
rs441701417 693 N>H No EVA
rs461931967 708 K>N No EVA

No associated diseases with Q6T8E9

9 regional properties for Q6T8E9

Type Name Position InterPro Accession
domain Ubiquitin-like domain 1 - 73 IPR000626
domain IBR domain 313 - 377 IPR002867-1
domain IBR domain 401 - 457 IPR002867-2
domain RING/Ubox-like zinc-binding domain 228 - 318 IPR041170
domain Parkin, RING/Ubox like zinc-binding domain 145 - 217 IPR041565
domain TRIAD supradomain 234 - 465 IPR044066
domain E3 ubiquitin-protein ligase parkin, BRcat domain 301 - 381 IPR047534
domain E3 ubiquitin-protein ligase parkin, RING finger, HC subclass 236 - 294 IPR047535
domain E3 ubiquitin-protein ligase parkin, Rcat domain 409 - 463 IPR047536

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cyclin/CDK positive transcription elongation factor complex A transcription elongation factor complex that facilitates the transition from abortive to productive elongation by phosphorylating the CTD domain of the large subunit of DNA-directed RNA polymerase II, holoenzyme. Contains a cyclin and a cyclin-dependent protein kinase catalytic subunit.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
P-TEFb complex A dimeric positive transcription elongation factor complex b that comprises a cyclin-dependent kinase containing the catalytic subunit, Cdk9, and a regulatory subunit, cyclin T.

3 GO annotations of molecular function

Name Definition
7SK snRNA binding Binding to a 7SK small nuclear RNA (7SK snRNA).
cyclin-dependent protein serine/threonine kinase activator activity Binds to and increases the activity of a cyclin-dependent protein serine/threonine kinase.
molecular condensate scaffold activity Binding and bringing together two or more macromolecules in contact, permitting those molecules to organize as a molecular condensate.

5 GO annotations of biological process

Name Definition
cell cycle The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.
cell division The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells.
positive regulation of DNA-templated transcription, elongation Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides catalyzed by a DNA-dependent RNA polymerase.
positive regulation of transcription elongation by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.

14 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q3ZCK5 CCNC Cyclin-C Bos taurus (Bovine) PR
Q3ZBL9 CCNH Cyclin-H Bos taurus (Bovine) PR
Q8HXN7 CCNT1 Cyclin-T1 Pan troglodytes (Chimpanzee) SS
Q9XT26 CCNT1 Cyclin-T1 Equus caballus (Horse) SS
O75909 CCNK Cyclin-K Homo sapiens (Human) PR
Q8N1B3 CCNQ Cyclin-Q Homo sapiens (Human) PR
O60563 CCNT1 Cyclin-T1 Homo sapiens (Human) EV
O88874 Ccnk Cyclin-K Mus musculus (Mouse) PR
Q9QWV9 Ccnt1 Cyclin-T1 Mus musculus (Mouse) SS
Q2QQS5 CYCT1-1 Cyclin-T1-4 Oryza sativa subsp japonica (Rice) PR
Q6Z7H3 CYCT1_2 Cyclin-T1-2 Oryza sativa subsp japonica (Rice) PR
Q2RAC5 CYCT1-3 Cyclin-T1-3 Oryza sativa subsp japonica (Rice) PR
Q8GYM6 CYCT1-4 Cyclin-T1-4 Arabidopsis thaliana (Mouse-ear cress) PR
Q503D6 ccnq Cyclin-Q Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MEGERKNNNK RWYFTREQLE NSPSRRFGLD PDKELSNRQQ AANLLQDMGQ RLNVSQLTIN
70 80 90 100 110 120
TAIVYMHRFY MIQSFTQFHR NSVAPAALFL AAKVEEQPKK LEHVIKVAHT CLHPQESLPD
130 140 150 160 170 180
TRSEAYLQQV QDLVILESII LQTLGFELTI DHPHTHVVKC TQLVRASKDL AQTSYFMATN
190 200 210 220 230 240
SLHLTTFSLQ YTPPVVACVC IHLACKWSNW EIPVSTDGKH WWEYVDATVT LELLDELTHE
250 260 270 280 290 300
FLQILEKTPN RLKRIWNWRA WQADRKTKAD DRGADENSSE QTILNMISQS SSDTTIAGLM
310 320 330 340 350 360
SMSASSTTSA VPSLPATEDS KSNLSNVEML SSERWLSSHP PFKVEPAQGY RKSENLALVG
370 380 390 400 410 420
ADHSLQQDGS NAFVSQKQNS KSVPSAKVSL KEYRAKHAEE LAAQKRQLEN MEANVKSQYA
430 440 450 460 470 480
YAAQNLLSHH DSHSSVILKM PIEGSENPER PFLEKTDKTA LKMRIPMTGG DKAASIKPEE
490 500 510 520 530 540
IKMRIKVHTA ADKHNSVDDS VTKNREHKEK HKTHPSNHHH HHNHHSHKHS HSQLPAGTGN
550 560 570 580 590 600
KRLGDPKHSS QTSTLAHKPY SLSSSFSSSS SSRKRPLPEE TGGVAYDHST KTAKSAKSSS
610 620 630 640 650 660
INFSFPPLPT MAQLPGHSSD TSGLHFSQPS CKTRVPHMKL DKSSTGANSH NTPQTTDYQD
670 680 690 700 710 720
TVNMLNSLLN AQGVQPTQPP AFEYVHSYGE YMNPRAGGMS SRSGNTDKPR PPPLPSEPPP
PLPPLPK